Jane Street Group, LLC Crispr Therapeutics Ag Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $5.87 Million - $8.26 Million
131,600 New
131,600 $6.18 Million
Q1 2022

May 17, 2022
SELL
$53.19 - $79.24 $5.66 Million - $8.43 Million
-106,400 Reduced 27.44%
281,400 $17.7 Million
Q4 2021

Feb 15, 2022
BUY
$70.09 - $111.29 $525,675 - $834,675
7,500 Added 1.97%
387,800 $29.4 Million
Q3 2021

Nov 16, 2021
SELL
$110.2 - $156.64 $13.4 Million - $19 Million
-121,300 Reduced 24.18%
380,300 $42.6 Million
Q2 2021

Aug 16, 2021
BUY
$100.84 - $161.89 $1.88 Million - $3.01 Million
18,600 Added 3.85%
501,600 $81.2 Million
Q1 2021

May 18, 2021
BUY
$110.72 - $210.04 $21 Million - $39.9 Million
189,900 Added 64.79%
483,000 $58.9 Million
Q4 2020

Feb 17, 2021
BUY
$79.67 - $173.23 $11.8 Million - $25.6 Million
147,800 Added 101.72%
293,100 $44.9 Million
Q3 2020

Nov 17, 2020
BUY
$78.5 - $100.64 $2.44 Million - $3.13 Million
31,100 Added 27.23%
145,300 $12.2 Million
Q2 2020

Aug 17, 2020
BUY
$38.5 - $76.05 $3.92 Million - $7.73 Million
101,700 Added 813.6%
114,200 $8.39 Million
Q1 2020

May 15, 2020
BUY
$33.68 - $62.53 $195,344 - $362,674
5,800 Added 86.57%
12,500 $530,000
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $245,756 - $489,970
6,700 New
6,700 $408,000

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email